Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Summit Therapeutics (SMMT)

Summit Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:SMMT
DateTimeSourceHeadlineSymbolCompany
14/02/202415:29Business WireSummit Therapeutics to Host Fourth Quarter & Full Year 2023 Financial Results & Operational Progress Call on February 20, 2024NASDAQ:SMMTSummit Therapeutics Inc
14/02/202412:00Business WireSummit Therapeutics to Host Fourth Quarter & Full Year 2023NASDAQ:SMMTSummit Therapeutics Inc
07/02/202412:00Business WireSummit Therapeutics to Present at Oppenheimer’s 34th Annual Healthcare Life Sciences ConferenceNASDAQ:SMMTSummit Therapeutics Inc
08/01/202414:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SMMTSummit Therapeutics Inc
08/01/202414:00Business WireSummit Therapeutics Announces Updated Phase II Data for Ivonescimab at 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:SMMTSummit Therapeutics Inc
04/01/202421:33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SMMTSummit Therapeutics Inc
04/01/202421:22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SMMTSummit Therapeutics Inc
04/01/202421:19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SMMTSummit Therapeutics Inc
03/01/202421:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SMMTSummit Therapeutics Inc
03/01/202412:30Business WireSummit Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:SMMTSummit Therapeutics Inc
13/12/202321:49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SMMTSummit Therapeutics Inc
07/11/202313:08Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SMMTSummit Therapeutics Inc
07/11/202313:03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SMMTSummit Therapeutics Inc
07/11/202312:00Business WireSummit Therapeutics Reports Financial Results and Operational Progress for the Third Quarter and Nine Months Ended September 30, 2023NASDAQ:SMMTSummit Therapeutics Inc
02/11/202320:41Business WireLaura Chow, MD, Cancer Immunotherapy Trailblazer, Joins Summit as Senior Vice President of Clinical DevelopmentNASDAQ:SMMTSummit Therapeutics Inc
31/10/202320:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SMMTSummit Therapeutics Inc
31/10/202312:00Business WireIvonescimab’s Novel Mechanism of Action Highlighting Cooperative Binding to be Featured in Poster Presentation at SITC 2023NASDAQ:SMMTSummit Therapeutics Inc
26/10/202313:00Business WireSummit Therapeutics to Host Q3 2023 Financial Results & Operational Progress Call on November 7, 2023NASDAQ:SMMTSummit Therapeutics Inc
19/10/202313:00Business WireH. Jack West, MD, Renowned Oncologist & Lung Cancer Expert, Joins Summit Therapeutics as Vice President of Clinical DevelopmentNASDAQ:SMMTSummit Therapeutics Inc
16/10/202312:46Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SMMTSummit Therapeutics Inc
16/10/202312:00Business WireSummit Therapeutics Appoints Proven Biotech Leader Manmeet S. Soni as Chief Operating OfficerNASDAQ:SMMTSummit Therapeutics Inc
19/09/202320:40Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:SMMTSummit Therapeutics Inc
08/09/202321:08Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:SMMTSummit Therapeutics Inc
09/08/202321:03Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SMMTSummit Therapeutics Inc
09/08/202313:03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SMMTSummit Therapeutics Inc
09/08/202312:00Business WireSummit Therapeutics Reports Financial Results and Operational Progress for the Second Quarter and Six Months Ended June 30, 2023NASDAQ:SMMTSummit Therapeutics Inc
02/08/202321:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SMMTSummit Therapeutics Inc
02/08/202313:00Business WireSummit Therapeutics to Host Q2 2023 Financial Results & Operational Progress Call on August 9, 2023NASDAQ:SMMTSummit Therapeutics Inc
05/06/202313:44Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SMMTSummit Therapeutics Inc
04/06/202313:00Business WirePromising Data for Investigational Innovative Bispecific Ivonescimab Featured at ASCO 2023NASDAQ:SMMTSummit Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:SMMT